GLIVEC 400 MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1006801740090 -
GGREM
526523020100903 -
Código de barras
7896261022454 -
Código de barras
7896261024144
O que a fonte publica
- Detentor do registro
- NOVARTIS BIOCIENCIAS S.A
- Princípios ativos
- MESILATO DE IMATINIBE
- Embalagem
- 400 MG COM REV CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H1 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BCR-ABL
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "GLIVEC 400 MG COM REV CT BL AL AL X 30",
"holder": "NOVARTIS BIOCIENCIAS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896261022454",
"7896261024144"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526523020100903",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "56.994.502/0001-30",
"priceRegime": "Regulado",
"productName": "GLIVEC",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "400 MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "17844.85",
"icms-12": "20278.25",
"icms-17": "21499.81",
"icms-18": "21762.01",
"icms-19": "22030.68",
"icms-20": "22306.06",
"icms-21": "22588.42",
"icms-22": "22878.01",
"icms-23": "23175.12",
"icms-17.5": "21630.12",
"icms-19.5": "22167.52",
"icms-20.5": "22446.36",
"icms-22.5": "23025.62",
"icms-12-alc": "20034.89",
"icms-17-alc": "21241.81",
"icms-18-alc": "21500.87",
"icms-19-alc": "21766.31",
"icms-20-alc": "22038.37",
"icms-21-alc": "22317.36",
"icms-22-alc": "22603.46",
"icms-23-alc": "22897.01",
"withoutTaxes": "17630.71",
"icms-17.5-alc": "21370.55",
"icms-19.5-alc": "21901.50",
"icms-20.5-alc": "22176.99",
"icms-22.5-alc": "22749.31"
},
"pisCofinsList": "Positiva",
"substanceText": "MESILATO DE IMATINIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "24597.27",
"icms-12": "27951.46",
"icms-17": "29635.25",
"icms-18": "29996.66",
"icms-19": "30367.00",
"icms-20": "30746.58",
"icms-21": "31135.78",
"icms-22": "31534.95",
"icms-23": "31944.49",
"icms-17.5": "29814.87",
"icms-19.5": "30555.62",
"icms-20.5": "30939.97",
"icms-22.5": "31738.42",
"icms-12-alc": "27697.06",
"icms-17-alc": "29365.56",
"icms-18-alc": "29723.69",
"icms-19-alc": "30090.65",
"icms-20-alc": "30466.75",
"icms-21-alc": "30852.44",
"icms-22-alc": "31247.96",
"icms-23-alc": "31653.77",
"withoutTaxes": "24373.42",
"icms-17.5-alc": "29543.53",
"icms-19.5-alc": "30277.54",
"icms-20.5-alc": "30658.39",
"icms-22.5-alc": "31449.59"
},
"invalidBarcodes": [],
"activeSubstances": [
"MESILATO DE IMATINIBE"
],
"therapeuticClass": "L1H1 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BCR-ABL",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006801740090",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526523020100903"